Literature DB >> 25307018

Altered nuclear structure in myotonic dystrophy type 1-derived fibroblasts.

R Rodríguez1, O Hernández-Hernández, J J Magaña, R González-Ramírez, E S García-López, B Cisneros.   

Abstract

Myotonic dystrophy type 1 (DM1) is a multisystem genetic disorder caused by a triplet nucleotide repeat expansion in the 3' untranslated region of the Dystrophia Myotonica-Protein Kinase (DMPK) gene. DMPK gene transcripts containing CUG expanded repeats accumulate in nuclear foci and ultimately cause altered splicing/gene expression of numerous secondary genes. The study of primary cell cultures derived from patients with DM1 has allowed the identification and further characterization of molecular mechanisms underlying the pathology in the natural context of the disease. In this study we show for the first time impaired nuclear structure in fibroblasts of DM1 patients. DM1-derived fibroblasts exhibited altered localization of the nuclear envelope (NE) proteins emerin and lamins A/C and B1 with concomitant increased size and altered shape of nuclei. Abnormal NE organization is more common in DM1 fibroblasts containing abundant nuclear foci, implying expression of the expanded RNA as determinant of nuclear defects. That transient expression of the DMPK 3' UTR containing 960 CTG but not with the 3' UTR lacking CTG repeats is sufficient to generate NE disruption in normal fibroblasts confirms the direct impact of mutant RNA on NE architecture. We also evidence nucleoli distortion in DM1 fibroblasts by immunostaining of the nucleolar protein fibrillarin, implying a broader effect of the mutant RNA on nuclear structure. In summary, these findings reveal that NE disruption, a hallmark of laminopathy disorders, is a novel characteristic of DM1.

Entities:  

Mesh:

Year:  2014        PMID: 25307018     DOI: 10.1007/s11033-014-3791-4

Source DB:  PubMed          Journal:  Mol Biol Rep        ISSN: 0301-4851            Impact factor:   2.316


  54 in total

1.  Biochemical and histochemical analysis of 71 kDa dystrophin isoform (Dp71f) in rat brain.

Authors:  C G Garcia-Tovar; A Perez; J Luna; R Mena; B Osorio; V Aleman; R Mondragon; D Mornet; A Rendón; J M Hernandez
Journal:  Acta Histochem       Date:  2001-04       Impact factor: 2.479

2.  Preferential nucleosome assembly at DNA triplet repeats from the myotonic dystrophy gene.

Authors:  Y H Wang; S Amirhaeri; S Kang; R D Wells; J D Griffith
Journal:  Science       Date:  1994-07-29       Impact factor: 47.728

Review 3.  Targeting the nucleolus for cancer intervention.

Authors:  Jaclyn E Quin; Jennifer R Devlin; Donald Cameron; Kate M Hannan; Richard B Pearson; Ross D Hannan
Journal:  Biochim Biophys Acta       Date:  2014-01-02

4.  Aberrant regulation of insulin receptor alternative splicing is associated with insulin resistance in myotonic dystrophy.

Authors:  R S Savkur; A V Philips; T A Cooper
Journal:  Nat Genet       Date:  2001-09       Impact factor: 38.330

5.  Three proteins, MBNL, MBLL and MBXL, co-localize in vivo with nuclear foci of expanded-repeat transcripts in DM1 and DM2 cells.

Authors:  Majid Fardaei; Mark T Rogers; Helena M Thorpe; Kenneth Larkin; Marion G Hamshere; Peter S Harper; J David Brook
Journal:  Hum Mol Genet       Date:  2002-04-01       Impact factor: 6.150

6.  Cis and trans effects of the myotonic dystrophy (DM) mutation in a cell culture model.

Authors:  J D Amack; A P Paguio; M S Mahadevan
Journal:  Hum Mol Genet       Date:  1999-10       Impact factor: 6.150

7.  RNA leaching of transcription factors disrupts transcription in myotonic dystrophy.

Authors:  A Ebralidze; Y Wang; V Petkova; K Ebralidse; R P Junghans
Journal:  Science       Date:  2003-12-04       Impact factor: 47.728

8.  Decreased mechanical stiffness in LMNA-/- cells is caused by defective nucleo-cytoskeletal integrity: implications for the development of laminopathies.

Authors:  Jos L V Broers; Emiel A G Peeters; Helma J H Kuijpers; Jorike Endert; Carlijn V C Bouten; Cees W J Oomens; Frank P T Baaijens; Frans C S Ramaekers
Journal:  Hum Mol Genet       Date:  2004-09-14       Impact factor: 6.150

9.  Effects of triplet repeat sequences on nucleosome positioning and gene expression in yeast minichromosomes.

Authors:  Nobuyuki Tomita; Ryo Fujita; Daichi Kurihara; Heisaburo Shindo; Robert D Wells; Mitsuhiro Shimizu
Journal:  Nucleic Acids Res Suppl       Date:  2002

10.  Mutant DMPK 3'-UTR transcripts disrupt C2C12 myogenic differentiation by compromising MyoD.

Authors:  Jeffrey D Amack; Shannon R Reagan; Mani S Mahadevan
Journal:  J Cell Biol       Date:  2002-11-11       Impact factor: 10.539

View more
  12 in total

1.  Three-dimensional imaging reveals endo(sarco)plasmic reticulum-containing invaginations within the nucleoplasm of muscle.

Authors:  Shin-Haw Lee; Sina Hadipour-Lakmehsari; Tetsuaki Miyake; Anthony O Gramolini
Journal:  Am J Physiol Cell Physiol       Date:  2017-11-22       Impact factor: 4.249

2.  Polyglutamine-Expanded Huntingtin Exacerbates Age-Related Disruption of Nuclear Integrity and Nucleocytoplasmic Transport.

Authors:  Fatima Gasset-Rosa; Carlos Chillon-Marinas; Alexander Goginashvili; Ranjit Singh Atwal; Jonathan W Artates; Ricardos Tabet; Vanessa C Wheeler; Anne G Bang; Don W Cleveland; Clotilde Lagier-Tourenne
Journal:  Neuron       Date:  2017-04-05       Impact factor: 17.173

3.  Functional impact of an oculopharyngeal muscular dystrophy mutation in PABPN1.

Authors:  Maricela García-Castañeda; Ana Victoria Vega; Rocío Rodríguez; Maria Guadalupe Montiel-Jaen; Bulmaro Cisneros; Angel Zarain-Herzberg; Guillermo Avila
Journal:  J Physiol       Date:  2017-04-25       Impact factor: 5.182

Review 4.  Shared mechanisms in physiological and pathological nucleoplasmic reticulum formation.

Authors:  Marek Mateusz Drozdz; David John Vaux
Journal:  Nucleus       Date:  2016-10-31       Impact factor: 4.197

5.  Mutant TDP-43 within motor neurons drives disease onset but not progression in amyotrophic lateral sclerosis.

Authors:  Dara Ditsworth; Marcus Maldonado; Melissa McAlonis-Downes; Shuying Sun; Amanda Seelman; Kevin Drenner; Eveline Arnold; Shuo-Chien Ling; Donald Pizzo; John Ravits; Don W Cleveland; Sandrine Da Cruz
Journal:  Acta Neuropathol       Date:  2017-03-29       Impact factor: 17.088

6.  Nuclear Envelope Transmembrane Proteins in Myotonic Dystrophy Type 1.

Authors:  Stefan Hintze; Lisa Knaier; Sarah Limmer; Benedikt Schoser; Peter Meinke
Journal:  Front Physiol       Date:  2018-10-30       Impact factor: 4.566

Review 7.  Metabolic Alterations in Myotonic Dystrophy Type 1 and Their Correlation with Lipin.

Authors:  Tiago Mateus; Filipa Martins; Alexandra Nunes; Maria Teresa Herdeiro; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-02-12       Impact factor: 3.390

8.  Fourier-Transform Infrared Spectroscopy as a Discriminatory Tool for Myotonic Dystrophy Type 1 Metabolism: A Pilot Study.

Authors:  Tiago Mateus; Idália Almeida; Adriana Costa; Diana Viegas; Sandra Magalhães; Filipa Martins; Maria Teresa Herdeiro; Odete A B da Cruz E Silva; Carla Fraga; Ivânia Alves; Alexandra Nunes; Sandra Rebelo
Journal:  Int J Environ Res Public Health       Date:  2021-04-06       Impact factor: 3.390

9.  Nuclear Envelope Alterations in Myotonic Dystrophy Type 1 Patient-Derived Fibroblasts.

Authors:  Diana Viegas; Cátia D Pereira; Filipa Martins; Tiago Mateus; Odete A B da Cruz E Silva; Maria Teresa Herdeiro; Sandra Rebelo
Journal:  Int J Mol Sci       Date:  2022-01-04       Impact factor: 5.923

10.  Myotonic Dystrophy-A Progeroid Disease?

Authors:  Peter Meinke; Stefan Hintze; Sarah Limmer; Benedikt Schoser
Journal:  Front Neurol       Date:  2018-07-25       Impact factor: 4.003

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.